Just popping out l’essence. “CytoDyn is al
Post# of 149953
![](/assets/46931549/no_avatar_available_thumb.jpg)
“CytoDyn is also currently in discussions with a key opinion leader in neuro-oncology about the possibility of initiating a pilot study in patients with GBM based on Dr. Pestell’s unpublished work and the outcome of the follow-up preclinical study.”
From mouse to man…
Investors Hangout: https://investorshangout.com/post/view?id=674...z8zLo5PoMT
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)